ID
IDXX
HealthcareIDEXX Laboratories, Inc.
Diagnostics & Research
Total Trades
32
Unique Traders
5
Purchases / Sales
20/12
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Feb 24, 2026 |  Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $649.23 | $575.72 | -11.3% | -7.1% | |
Feb 17, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $626.17 | $579.85 | -7.4% | -4.0% | |
Jan 29, 2026 | Rohit KhannaD | Stock | Sell | $15,001 - $50,000 | $676.71 | $656.73 | -3.0% | -1.8% | |
Jan 23, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $693.85 | $635.66 | -8.4% | -8.4% | |
Jan 13, 2026 |  April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $714.04 | $648.73 | -9.1% | -8.9% | |
Dec 2, 2025 | April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $732.73 | $676.53 | -7.7% | -8.0% | |
Oct 29, 2025 | April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $627.66 | $752.88 | +20.0% | +20.5% | |
Oct 16, 2025 | April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $637.34 | $689.93 | +8.3% | +6.5% | |
Oct 7, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $627.28 | $713.74 | +13.8% | +13.6% | |
Sep 5, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $642.99 | $631.19 | -1.8% | -5.5% | |
Sep 4, 2025 |  Byron DonaldsR | Stock | Buy | $1,001 - $15,000 | $640.44 | $631.19 | -1.4% | -4.8% | |
Sep 4, 2025 | Byron DonaldsR | Stock | Buy | $1,001 - $15,000 | $640.44 | $631.19 | -1.4% | -4.8% | |
Aug 7, 2025 | April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $650.06 | $642.99 | -1.1% | -3.5% | |
Aug 4, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $682.78 | $633.95 | -7.2% | -9.1% | |
Aug 1, 2025 | April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $535.54 | $647.09 | +20.8% | +17.1% | |
Jul 9, 2025 | April McClain DelaneyD | Stock | Sell | $1,001 - $15,000 | $540.64 | $658.06 | +21.7% | +19.6% | |
May 15, 2025 |  Rob BresnahanR | Stock | Buy | $1,001 - $15,000 | $511.99 | $522.70 | +2.1% | +1.0% | |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $100,001 - $250,000 | $509.53 | $524.18 | +2.9% | -0.3% | |
Apr 23, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $426.63 | $501.57 | +17.6% | +9.4% | |
Apr 9, 2025 | April McClain DelaneyD | Stock | Buy | $1,001 - $15,000 | $397.10 | $491.70 | +23.8% | +21.0% | |
Apr 8, 2025 | Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $361.04 | $489.98 | +35.7% | +21.9% | |
Apr 7, 2025 | April McClain DelaneyD | Stock | Buy | $1,001 - $15,000 | $378.99 | $486.61 | +28.4% | +17.1% | |
Apr 7, 2025 | Jefferson ShreveR | Stock | Buy | $50,001 - $100,000 | $378.99 | $486.61 | +28.4% | +17.1% | |
Apr 4, 2025 | April McClain DelaneyD | Stock | Buy | $1,001 - $15,000 | $393.73 | $471.90 | +19.9% | +7.7% | |
Apr 1, 2025 | April McClain DelaneyD | Stock | Buy | $1,001 - $15,000 | $418.57 | $471.38 | +12.6% | +13.1% | |
Mar 14, 2025 | April McClain DelaneyD | Stock | Buy | $1,001 - $15,000 | $415.30 | $390.94 | -5.9% | -1.0% | |
Mar 13, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $406.29 | $390.94 | -3.8% | -0.9% | |
Mar 6, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $429.03 | $393.73 | -8.2% | +3.3% | |
Feb 25, 2025 | Rob BresnahanR | Stock | Buy | $1,001 - $15,000 | $459.86 | $422.54 | -8.1% | -3.8% | |
Feb 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $450.99 | $420.99 | -6.7% | +1.1% | |
Dec 18, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $410.76 | $419.26 | +2.1% | -0.2% | |
Dec 16, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $430.47 | $422.92 | -1.8% | +0.2% |
Recent News
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
Benzinga-Invalid Date
IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
SeekingAlpha-Invalid Date
Assessing IDEXX Laboratories (IDXX) Valuation After Recent Share Price Swings
Yahoo-Invalid Date
IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit
Yahoo-Invalid Date
IDEXX Laboratories, Inc. (IDXX) Presents at BofA Securities Animal Health Summit Transcript
SeekingAlpha-Invalid Date